Cite
MLA Citation
Shinya Kimura et al.. “Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial.” Lancet, vol. 7, no. 3, 2020, pp. e218–e225. http://access.bl.uk/ark:/81055/vdc_100101667476.0x00000d